Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Clinical Immunology (Orlando, Fla.)|March 14, 2017
The gut microbiome and microbial translocation in multiple sclerosisAli Mirza, Yang Mao-DraayerFrontiers in Neurology|April 21, 2017
Emerging Approaches for Validating and Managing Multiple Sclerosis RelapseElizabeth A Mills, Ali Mirza, Yang Mao-DraayerMultiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Alexia without agraphia in multiple sclerosis: case report with magnetic resonance imaging localizationYang Mao-Draayer, Hillel PanitchMultiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2018
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patientsElizabeth A Mills, Yang Mao-DraayerFrontiers in Immunology|February 20, 2018
Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye ViewElizabeth A Mills, Yang Mao-DraayerAmerican Journal of Translational Research|February 4, 2014
Transplantation of Fas-deficient or wild-type neural stem/progenitor cells (NPCs) is equally efficient in treating experimental autoimmune encephalomyelitis (EAE)Charles Hackett, Julia Knight, Yang Mao-DraayerNeural Regeneration Research|October 3, 2017
Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosisJohn Soltys, Qin Wang, Yang Mao-DraayerJournal of Immunology and Clinical Research|November 13, 2018
Assessment and Treatment Strategies for a Multiple Sclerosis RelapseCynthia Wang, America Ruiz, Yang Mao-DraayerBiochemical and Biophysical Research Communications|August 10, 2010
Regulation of neural progenitor cell fate by anandamideJohn Soltys, Melinda Yushak, Yang Mao-DraayerJournal of Neuroscience Research|October 16, 2009
Fas activation increases neural progenitor cell survivalJulia C Knight, Eugene L Scharf, Yang Mao-DraayerPageof 19